Cronos Group Inc. (7CI)
XDUS 
Summary
7CI Chart
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?
Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.
Cronos: Strong Q1 Earnings Driven By International Cannabis Sales
Cronos reported strong Q1 performance with record level revenue. International sales are driving growth and the Canadian markets are showing improvement. The company is set to acquire CanAdelaar in the Netherlands which will increase its international operations and revenue potential.
Cronos Group Q1 Earnings Call Highlights
Cronos Group NASDAQ: CRON reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued international expansion as key drivers of the quarter.
Cronos Group Inc. (7CI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Cronos Group Inc. ever had a stock split?
Cronos Group Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Michael Ryan Gorenstein CEO | XDUS Exchange | CA22717L1013 ISIN |
| CA Country | 610 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Cronos Group Inc. stands as a pioneering entity in the cannabinoid industry, dedicating its efforts to the cultivation, production, and distribution of cannabis products across notable markets in Canada, Israel, and Germany. Since its establishment in 2012, the company has positioned itself in Toronto, Canada, navigating the complexities of the ever-evolving cannabis landscape. Through strategic brand development and an unwavering commitment to quality, Cronos Group has carved a niche for itself, becoming synonymous with excellence in the realm of cannabinoid offerings.
Products and Services
- Dried Flower: Cronos Group offers a variety of premium dried cannabis flowers, catering to the traditional cannabis consumer. These products are carefully cultivated to ensure the highest quality and potency, meeting the diverse preferences and needs of their clientele.
- Pre-rolls: For those seeking convenience without compromising on quality, Cronos Group's pre-rolled cannabis offers an easy-to-use option. Expertly rolled from their top-quality dried flower, these pre-rolls provide a consistent and satisfying experience for both new and seasoned users.
- Oils: Cannabis oils by Cronos Group are extracted using state-of-the-art techniques to ensure purity and potency. These oils are versatile, designed for consumptions such as ingestion or topical application, catering to a wide range of medicinal and recreational uses.
- Vaporizers: Recognizing the growing demand for smoke-free alternatives, Cronos Group offers high-quality cannabis vaporizers. These devices are designed for convenient and discreet use, providing a modern approach to cannabis consumption.
- Edibles: Catering to the evolving tastes of their consumer base, Cronos Group has ventured into the world of cannabis-infused edibles. This range includes various ingestible forms, offering a delicious and controlled way to experience the effects of cannabis.
- Cannabis Tinctures: For those preferring direct ingestion or alternative application methods, Cronos Group's cannabis tinctures offer a potent and precise dosing solution. These liquid extracts can be consumed directly or mixed with food or drinks, providing flexibility in usage.
The product lineup is marketed under distinguished brands such as Spinach, Lord Jones, and PEACE NATURALS, each carrying a unique identity and clientele focus, thus allowing Cronos Group to cater to a broad spectrum of consumer needs and preferences.
